Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2008
10/30/2008WO2007140434A3 Immune-derived moieties reactive against lysophosphatidic acid
10/30/2008WO2007109307A3 Antibodies directed to angiopoietin-like protein 4 and uses thereof
10/30/2008WO2007089871A3 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
10/30/2008WO2007008859A3 Methods of enhancing the immune response to autoantigens in mucosal associated lymphatic tissue
10/30/2008WO2006078318A3 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
10/30/2008WO2004112717A3 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
10/30/2008US20080271167 for treatment of viral infection and nervous systtem disorders
10/30/2008US20080270283 Electronic trading data integration and protection system
10/30/2008US20080269875 Coating for a Medical Device Having an Anti-Thrombotic Conjugate
10/30/2008US20080269666 Microneedles and Methods for Microinfusion
10/30/2008US20080269537 Crustacean metallothionein polypeptide; bioremediation; pollution control
10/30/2008US20080269465 Tumor necrosis factor specific immunoglobulin for use in prevention and treatment of rheumatoid arthritis, ulcerative colitis, multiple sclerosis and crohn's disease
10/30/2008US20080269462 Peptide inhibitors of HIV entry
10/30/2008US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
10/30/2008US20080269317 Compounds for Covalent Binding to MD-2 and Effect on the Immune Response
10/30/2008US20080269308 Allantoin-containing skin cream
10/30/2008US20080269304 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
10/30/2008US20080269298 anticarcinogenic agent, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide; for treatment of susceptible neoplasm selected from breast, colon, lung, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma, ovarian, pancreatic, head and neck
10/30/2008US20080269160 Immune response against antigen in vivo; gold particle bombardment, nucleotide sequence encoding chimeric protein, antigen in one nucleic acid in an adenoviral vector; chimeric protein is myristoylation membrane targeting region; AP1903 ligand-binding region; CD40 cytoplasmic polypeptide region
10/30/2008US20080269151 Antigen, nucleic acid that encodes fusion protein; diagnosis, prevention, therapy of tuberculosis
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268063 Coated Controlled Release Polymer Particles as Efficient Oral Delivery Vehicles for Biopharmaceuticals
10/30/2008US20080268061 injection solutions containing the nanoparticles as well as to the use thereof for the treatment of cancer; release of the therapeutically active substances is caused, initiated or substantially enhanced by an alternating magnetic field
10/30/2008US20080268051 Anti-angiogenesis; viscosity inducing component is injectable into the vitreous of a mammalian eye without permanently diminishing visual acuity
10/30/2008US20080268032 Stabilizing Alkylglycoside Compositions and Methods Thereof
10/30/2008US20080268029 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases
10/30/2008US20080267999 Neoepitope detection of disease using protein arrays
10/30/2008US20080267998 Combinations of gene deletions for live attenuated shigella vaccine strains
10/30/2008US20080267997 Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases
10/30/2008US20080267996 Compositions for inducing an immune response against hepatitis B
10/30/2008US20080267995 Administering a recombinantly produced protein encoded by one of the open reading frames in the porcine circovirus type 2 antigen genome
10/30/2008US20080267994 in vitro culturing; producing immunostimulants for a specific immune response and individuals who suffer from HIV infection, certain cancers, allergies, have received transplants; Acute Myeloid Leukemia cancers treatments, and autoimmune diseases such as Systemic Lupus Erythematosus; anti-viral cytokines
10/30/2008US20080267993 Administering Human Immunodeficiency Virus type 1 Envelope (env) sequence having a first set of consensus glycosylation sequences, followed by a second immunogen comprising a primate immunodeficiency virus env sequence having a second set of consensus glycosylation sequences
10/30/2008US20080267992 Sars Virus Vaccine with Adenovirus Carrier and Preparation Method Thereof, and Use of Sars Virus S Gene for Preparation of Vaccine
10/30/2008US20080267990 Nucleotide sequences coding interferon inducer for use in detection of mycobacterial infection
10/30/2008US20080267989 Self aggregating monomeric fusion protein for use in induction of immune response to human immunodeficiency viral infection
10/30/2008US20080267988 Myelin specific IgE unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
10/30/2008US20080267987 Major histocompatibility complex polypeptide for use in targeting, detecting and purifying antigen-specific T-cells; for treatment and prevention of inflammatory, arthritic and autoimmune disease
10/30/2008US20080267986 Using beta amyloid antigenic fragment to produce vaccine for prevention and treatment of autoimmune, nervous system and diabetic disorders
10/30/2008US20080267985 Major allergen Phl p 1 comprising reduced immunoglobulin reactivity for use in treating grass pollen allergies; immunotherapy
10/30/2008US20080267984 Using low density lipoprotein receptor specific immunoglobulin to increase receptor expression on antigen presenting cells; immunotherapy; treating infection, autoimmune, graft vs host and allergic disorders
10/30/2008US20080267983 Mimetic peptide for use in treatment and prevention of stroke, cardiovascular, neurodegenerative, inflammatory and vision defects
10/30/2008US20080267982 Generating E7 oncoprotein specific immunoglobulin for use as evaluative tool in diagnosing urogenital cell proliferative, brain and prion disorders
10/30/2008US20080267981 Treating neoplastic diseases with antibody-cytotoxin conjugate (duocarmycins); integrins; 3-[5-(1-(3-aminopropyl)indole-2-carbonyl)aminoindole-2-carbonyl]-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benz[e]indole
10/30/2008US20080267980 Complement Receptor 2 Targeted Complement Modulators
10/30/2008US20080267979 Heparan sulfate proteoglycan specific immunoglobulin for use in treatment and prevention of liver cancers
10/30/2008US20080267978 Using alpha 2 beta 1 integrin specific immunoglobulin for prevention, diagnosis and treatment of cell proliferative disorders
10/30/2008US20080267977 Combined immunological agent and sensitizing agent for the treatment of cancer
10/30/2008US20080267976 Optimized Anti-Cd30 Antibodies
10/30/2008US20080267975 Using lymphocyte profiles comprising aberrant transmembrane receptor tyrosine kinase (Mer) expression as evaluative tool in screening for blood clotting and/or cell proliferative disorders
10/30/2008US20080267974 Tumor necrosis factor specific immunoglobulin for use in diagnosis and treatment of autoimmune diseases
10/30/2008US20080267973 Diagnosis and Treatment of Siglec-6 Associated Diseases
10/30/2008US20080267972 Donor Lymphocyte Infusion of T Cells For the Treatment of Cancer
10/30/2008US20080267971 Antibodies Directed to Angiopoietin-2 and Uses Thereof
10/30/2008US20080267970 Sulfonamide Derivatives For The Treatment of Diseases
10/30/2008US20080267969 Treatment of Pulmonary Hypertension Using an Agent That Inhibits a Tissue Factor Pathway
10/30/2008US20080267968 Using cocktail comprising endothelial growth factor specific immunoglobulin and chemotherapeutic agent to treat and/or prevent cervical cancer
10/30/2008US20080267967 Modulation of cd200 receptors
10/30/2008US20080267966 Polypeptides from Non-Typeable Haemophilus Influenzae
10/30/2008US20080267965 Use of Bcma as an Immunoregulatory Agent
10/30/2008US20080267964 Synergistic Effect of Tgf-Beta Blockade and Immunogenic Agents on Tumors
10/30/2008US20080267963 Administering individual an antigen-liposome preparation to treat and prevent cell proliferative disorders
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267961 SOLUBLE ErbB3 AND TREATMENT OF CANCER
10/30/2008US20080267960 Methods of treating neoplastic, autoimmune and inflammatory diseases
10/30/2008US20080267959 Interleukin-13 specific immunoglobulin for treatment of asthma, skin, vision, inflammatory, cell proliferative, fibrotic and allergic disorders
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267957 Combination cancer therapy
10/30/2008US20080267956 Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
10/30/2008US20080267955 Frizzled 9 as tumor marker
10/30/2008US20080267954 Cell surface glycoprotein (CD52) specific monoclonal antibody for use in treatment of autoimmune diseases
10/30/2008US20080267953 Anti-perp recombinant antibody
10/30/2008US20080267952 Using concentration of immunoglobulins specific oxidized forms of amyloid beta in blood as evalauative indicator of alzheimer's disease
10/30/2008US20080267951 Methods for Treating Cancer Using Agents That Inhibit Wnt16 Signaling
10/30/2008US20080267950 Molecular determinants of myeloma bone disease and uses thereof
10/30/2008US20080267949 Peptides capable of binding to serum proteins
10/30/2008US20080267948 Croos-B Structure Binding Compounds
10/30/2008US20080267947 Stabilizes, reduces or eliminates cancer stem cells
10/30/2008US20080267946 Using transforming growth factor specific immunglobulin as therapeutic in treatment of hereditary vision defect
10/30/2008US20080267945 Salts of Isophosphoramide Mustard and Analogs Thereof as Anti-Tumor Agents
10/30/2008US20080267920 Monoparamunity inducers based on attenuated rabbit myxomaviruses
10/30/2008US20080267913 Method to enhance hematopoiesis
10/30/2008US20080267912 Novel inhibitors of glutaminyl cyclase
10/30/2008US20080267911 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/30/2008US20080267910 Nucleotide sequences coding interleukin-21/22 for use in identifying modulators for prevention and treatment of viral infection and cell proliferative disorders
10/30/2008US20080267908 Using alteration in interleukin-32 binding to proteinase-3 to identify compounds which maybe useful in treatment of inflammatory disorders
10/30/2008US20080267905 Antiinflammatory; angiogenesis inhibitors; synergistic; kits
10/30/2008US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
10/30/2008US20080267865 Targeting of Erb Antigens
10/30/2008US20080267864 Cancerous disease modifying antibodies
10/30/2008US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer
10/30/2008US20080267862 Method of treating cancer
10/30/2008CA2685185A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008CA2685182A1 Osteopontin functional epitopes, monoclonal antibody against the epitopes and uses thereof
10/30/2008CA2685123A1 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
1 ... 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 ... 1823